{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/hhs/rules/recent","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.federalregister.gov/agencies/health-and-human-services-department","generated_at":"2026-05-21T07:13:14.753Z"},"count":50,"items":[{"document_number":"2026-09335","title":"Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection","publication_date":"2026-05-12","effective_date":"2026-05-12","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 866","citation":"91 FR 25783","html_url":"https://www.federalregister.gov/documents/2026/05/12/2026-09335/medical-devices-immunology-and-microbiology-devices-classification-of-the-device-to-detect-and","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-09335"},{"document_number":"2026-09382","title":"Restoring Flexibility in the Child Care and Development Fund (CCDF)","publication_date":"2026-05-12","effective_date":"2026-07-13","category":"other","sub_agency":"HHS","cfr_part":"45 CFR 98","citation":"91 FR 25796","html_url":"https://www.federalregister.gov/documents/2026/05/12/2026-09382/restoring-flexibility-in-the-child-care-and-development-fund-ccdf","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-09382"},{"document_number":"2026-09266","title":"Extension of Compliance Dates for Nondiscrimination on the Basis of Disability; Accessibility of Web Content and Mobile Applications of Recipients of Departmental Financial Assistance","publication_date":"2026-05-11","effective_date":"2026-05-07","category":"other","sub_agency":"HHS","cfr_part":"45 CFR 84","citation":"91 FR 25496","html_url":"https://www.federalregister.gov/documents/2026/05/11/2026-09266/extension-of-compliance-dates-for-nondiscrimination-on-the-basis-of-disability-accessibility-of-web","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-09266"},{"document_number":"2026-09152","title":"Medical Devices; Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse","publication_date":"2026-05-08","effective_date":"2026-05-08","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 884","citation":"91 FR 25109","html_url":"https://www.federalregister.gov/documents/2026/05/08/2026-09152/medical-devices-obstetrical-and-gynecological-devices-classification-of-the-external-condom-for-anal","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-09152"},{"document_number":"2026-08813","title":"Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals","publication_date":"2026-05-06","effective_date":"2026-05-06","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 886","citation":"91 FR 24346","html_url":"https://www.federalregister.gov/documents/2026/05/06/2026-08813/medical-devices-ophthalmic-devices-classification-of-the-corneal-storage-medium-with-preservatives","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-08813"},{"document_number":"2026-08812","title":"Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device","publication_date":"2026-05-06","effective_date":"2026-05-06","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 866","citation":"91 FR 24343","html_url":"https://www.federalregister.gov/documents/2026/05/06/2026-08812/medical-devices-immunology-and-microbiology-devices-classification-of-the-circulating-tumor-cell","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-08812"},{"document_number":"2026-08811","title":"Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples","publication_date":"2026-05-06","effective_date":"2026-05-06","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 866","citation":"91 FR 24341","html_url":"https://www.federalregister.gov/documents/2026/05/06/2026-08811/medical-devices-immunology-and-microbiology-devices-classification-of-the-device-to-preserve-and","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-08811"},{"document_number":"2026-08497","title":"Medical Devices; General and Plastic Surgery Devices; Classification of the Phototherapy Device for Reducing the Appearance of Acute Post-Surgical Incisions","publication_date":"2026-05-01","effective_date":"2026-05-01","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 878","citation":"91 FR 23357","html_url":"https://www.federalregister.gov/documents/2026/05/01/2026-08497/medical-devices-general-and-plastic-surgery-devices-classification-of-the-phototherapy-device-for","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-08497"},{"document_number":"2026-08425","title":"Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System","publication_date":"2026-04-30","effective_date":"2026-04-30","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 882","citation":"91 FR 23163","html_url":"https://www.federalregister.gov/documents/2026/04/30/2026-08425/medical-devices-neurological-devices-classification-of-the-brain-temperature-measurement-system","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-08425"},{"document_number":"2026-08424","title":"Medical Devices; Radiology Devices; Classification of the Radiation Therapy Marking Device","publication_date":"2026-04-30","effective_date":"2026-04-30","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 892","citation":"91 FR 23166","html_url":"https://www.federalregister.gov/documents/2026/04/30/2026-08424/medical-devices-radiology-devices-classification-of-the-radiation-therapy-marking-device","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-08424"},{"document_number":"2026-08426","title":"Medical Devices; Cardiovascular Devices; Classification of the Laser-Powered Inferior Vena Cava Filter Retrieval Catheter","publication_date":"2026-04-30","effective_date":"2026-04-30","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 870","citation":"91 FR 23161","html_url":"https://www.federalregister.gov/documents/2026/04/30/2026-08426/medical-devices-cardiovascular-devices-classification-of-the-laser-powered-inferior-vena-cava-filter","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-08426"},{"document_number":"2026-07861","title":"Medical Devices; Ophthalmic Devices; Classification of the Digital Therapy Device for Amblyopia","publication_date":"2026-04-22","effective_date":"2026-04-22","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 882","citation":"91 FR 21383","html_url":"https://www.federalregister.gov/documents/2026/04/22/2026-07861/medical-devices-ophthalmic-devices-classification-of-the-digital-therapy-device-for-amblyopia","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-07861"},{"document_number":"2026-07863","title":"Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System","publication_date":"2026-04-22","effective_date":"2026-04-22","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 862","citation":"91 FR 21376","html_url":"https://www.federalregister.gov/documents/2026/04/22/2026-07863/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-07863"},{"document_number":"2026-07862","title":"Medical Devices; Anesthesiology Devices; Classification of the Device for Sleep Apnea Testing Based on Mandibular Movement","publication_date":"2026-04-22","effective_date":"2026-04-22","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 868","citation":"91 FR 21381","html_url":"https://www.federalregister.gov/documents/2026/04/22/2026-07862/medical-devices-anesthesiology-devices-classification-of-the-device-for-sleep-apnea-testing-based-on","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-07862"},{"document_number":"2026-07860","title":"Medical Devices; Immunology and Microbiology Devices; Classification of the Alzheimer's Disease Pathology Assessment Test","publication_date":"2026-04-22","effective_date":"2026-04-22","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 866","citation":"91 FR 21379","html_url":"https://www.federalregister.gov/documents/2026/04/22/2026-07860/medical-devices-immunology-and-microbiology-devices-classification-of-the-alzheimers-disease","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-07860"},{"document_number":"2026-07366","title":"Physical Medicine Devices; Reclassification of Non-Invasive Bone Growth Stimulators","publication_date":"2026-04-16","effective_date":"2026-05-18","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 890","citation":"91 FR 20352","html_url":"https://www.federalregister.gov/documents/2026/04/16/2026-07366/physical-medicine-devices-reclassification-of-non-invasive-bone-growth-stimulators","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-07366"},{"document_number":"2026-07367","title":"Medical Devices; Orthopedic Devices; Classification of the Manual Surgical Instrument for Appropriate Patient Selection for Orthopedic Implant","publication_date":"2026-04-16","effective_date":"2026-04-16","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 888","citation":"91 FR 20350","html_url":"https://www.federalregister.gov/documents/2026/04/16/2026-07367/medical-devices-orthopedic-devices-classification-of-the-manual-surgical-instrument-for-appropriate","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-07367"},{"document_number":"2026-07500","title":"New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor; Change of Sponsor Address","publication_date":"2026-04-16","effective_date":"2026-04-16","category":"other","sub_agency":"FDA","cfr_part":"21 CFR 510","citation":"91 FR 20337","html_url":"https://www.federalregister.gov/documents/2026/04/16/2026-07500/new-animal-drugs-approval-of-new-animal-drug-applications-withdrawal-of-approval-of-new-animal-drug","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-07500"},{"document_number":"2026-07365","title":"Medical Devices; Ear, Nose, and Throat Devices; Classification of the Transcutaneous Electrical Nerve Stimulator for the Relief of Congestion","publication_date":"2026-04-16","effective_date":"2026-04-16","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 874","citation":"91 FR 20348","html_url":"https://www.federalregister.gov/documents/2026/04/16/2026-07365/medical-devices-ear-nose-and-throat-devices-classification-of-the-transcutaneous-electrical-nerve","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-07365"},{"document_number":"2026-06600","title":"Medicare Program; Contract Year 2027 and Certain Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program","publication_date":"2026-04-06","effective_date":"2026-06-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 422","citation":"91 FR 17384","html_url":"https://www.federalregister.gov/documents/2026/04/06/2026-06600/medicare-program-contract-year-2027-and-certain-contract-year-2026-policy-and-technical-changes-to","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-06600"},{"document_number":"2026-06027","title":"Reducing Bureaucracy and Burden for Refugee Resettlement Programs","publication_date":"2026-03-27","effective_date":"2026-05-26","category":"other","sub_agency":"HHS","cfr_part":"45 CFR 402","citation":"91 FR 14758","html_url":"https://www.federalregister.gov/documents/2026/03/27/2026-06027/reducing-bureaucracy-and-burden-for-refugee-resettlement-programs","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-06027"},{"document_number":"2026-05772","title":"General and Plastic Surgery Devices; Reclassification of Optical Diagnostic Devices for Melanoma Detection and Electrical Impedance Spectrometers, To Be Renamed Software-Aided Adjunctive Diagnostic Devices for Use on Skin Lesions by Physicians Trained in the Diagnosis and Management of Skin Cancer","publication_date":"2026-03-25","effective_date":"2026-04-24","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 878","citation":"91 FR 14445","html_url":"https://www.federalregister.gov/documents/2026/03/25/2026-05772/general-and-plastic-surgery-devices-reclassification-of-optical-diagnostic-devices-for-melanoma","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-05772"},{"document_number":"2026-05733","title":"Listing of Color Additive Exempt From Certification; Spirulina Extract; Delay of Effective Date","publication_date":"2026-03-24","effective_date":null,"category":"fda-food","sub_agency":"FDA","cfr_part":"21 CFR 73","citation":"91 FR 13966","html_url":"https://www.federalregister.gov/documents/2026/03/24/2026-05733/listing-of-color-additive-exempt-from-certification-spirulina-extract-delay-of-effective-date","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-05733"},{"document_number":"2026-05732","title":"Listing of Color Additive Exempt From Certification; Beetroot Red; Delay of Effective Date","publication_date":"2026-03-24","effective_date":null,"category":"fda-food","sub_agency":"FDA","cfr_part":"21 CFR 73","citation":"91 FR 13965","html_url":"https://www.federalregister.gov/documents/2026/03/24/2026-05732/listing-of-color-additive-exempt-from-certification-beetroot-red-delay-of-effective-date","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-05732"},{"document_number":"2026-05676","title":"Administrative Simplification; Adoption of Standards for Health Care Claims Attachments Transactions and Electronic Signatures","publication_date":"2026-03-24","effective_date":"2026-05-26","category":"hipaa-privacy","sub_agency":"HHS","cfr_part":"45 CFR 160","citation":"91 FR 14350","html_url":"https://www.federalregister.gov/documents/2026/03/24/2026-05676/administrative-simplification-adoption-of-standards-for-health-care-claims-attachments-transactions","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-05676"},{"document_number":"2026-04981","title":"Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels","publication_date":"2026-03-13","effective_date":null,"category":"other","sub_agency":"HHS","cfr_part":null,"citation":"91 FR 12308","html_url":"https://www.federalregister.gov/documents/2026/03/13/2026-04981/mandatory-guidelines-for-federal-workplace-drug-testing-programs-authorized-testing-panels","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-04981"},{"document_number":"2026-04797","title":"Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction","publication_date":"2026-03-12","effective_date":"2026-03-12","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 405","citation":"91 FR 12071","html_url":"https://www.federalregister.gov/documents/2026/03/12/2026-04797/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-04797"},{"document_number":"2026-04368","title":"Revising the National Drug Code Format and Drug Label Barcode Requirements","publication_date":"2026-03-05","effective_date":"2033-03-07","category":"fda-drug","sub_agency":"FDA","cfr_part":"21 CFR 201","citation":"91 FR 10749","html_url":"https://www.federalregister.gov/documents/2026/03/05/2026-04368/revising-the-national-drug-code-format-and-drug-label-barcode-requirements","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-04368"},{"document_number":"2026-03779","title":"Managed Care","publication_date":"2026-02-25","effective_date":null,"category":"other","sub_agency":"CMS","cfr_part":"42 CFR 438","citation":"91 FR 9140","html_url":"https://www.federalregister.gov/documents/2026/02/25/2026-03779/managed-care","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-03779"},{"document_number":"2026-03578","title":"Medicare Program; Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Overall Hospital Quality Star Rating; Hospital Price Transparency; and Notice of Closure of a Teaching Hospital and Opportunity To Apply for Available Slots; Correction","publication_date":"2026-02-23","effective_date":"2026-02-23","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 410","citation":"91 FR 8383","html_url":"https://www.federalregister.gov/documents/2026/02/23/2026-03578/medicare-program-hospital-outpatient-prospective-payment-and-ambulatory-surgical-center-payment","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-03578"},{"document_number":"2026-03577","title":"Medications for the Treatment of Opioid Use Disorder; Correction","publication_date":"2026-02-23","effective_date":"2026-02-23","category":"other","sub_agency":"HHS","cfr_part":"42 CFR 8","citation":"91 FR 8381","html_url":"https://www.federalregister.gov/documents/2026/02/23/2026-03577/medications-for-the-treatment-of-opioid-use-disorder-correction","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-03577"},{"document_number":"2026-03285","title":"Revocation of Methods of Analysis Regulation","publication_date":"2026-02-19","effective_date":"2026-03-23","category":"other","sub_agency":"FDA","cfr_part":"21 CFR 2","citation":"91 FR 7829","html_url":"https://www.federalregister.gov/documents/2026/02/19/2026-03285/revocation-of-methods-of-analysis-regulation","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-03285"},{"document_number":"2026-03286","title":"Revocation of Regulations Regarding the Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and the European Community","publication_date":"2026-02-19","effective_date":"2026-03-23","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 26","citation":"91 FR 7825","html_url":"https://www.federalregister.gov/documents/2026/02/19/2026-03286/revocation-of-regulations-regarding-the-mutual-recognition-of-pharmaceutical-good-manufacturing","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-03286"},{"document_number":"2026-02313","title":"Listing of Color Additives Exempt From Certification; Beetroot Red","publication_date":"2026-02-06","effective_date":"2026-03-23","category":"fda-food","sub_agency":"FDA","cfr_part":"21 CFR 73","citation":"91 FR 5295","html_url":"https://www.federalregister.gov/documents/2026/02/06/2026-02313/listing-of-color-additives-exempt-from-certification-beetroot-red","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-02313"},{"document_number":"2026-02331","title":"New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor; Change of Sponsor Address","publication_date":"2026-02-06","effective_date":"2026-02-06","category":"other","sub_agency":"FDA","cfr_part":"21 CFR 516","citation":"91 FR 5299","html_url":"https://www.federalregister.gov/documents/2026/02/06/2026-02331/new-animal-drugs-approval-of-new-animal-drug-applications-withdrawal-of-approval-of-new-animal-drug","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-02331"},{"document_number":"2026-02314","title":"Listing of Color Additives Exempt From Certification; Spirulina Extract","publication_date":"2026-02-06","effective_date":"2026-03-23","category":"fda-food","sub_agency":"FDA","cfr_part":"21 CFR 73","citation":"91 FR 5291","html_url":"https://www.federalregister.gov/documents/2026/02/06/2026-02314/listing-of-color-additives-exempt-from-certification-spirulina-extract","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-02314"},{"document_number":"2026-02040","title":"Medicaid Program; Preserving Medicaid Funding for Vulnerable Populations-Closing a Health Care-Related Tax Loophole","publication_date":"2026-02-02","effective_date":"2026-04-03","category":"medicaid","sub_agency":"CMS","cfr_part":"42 CFR 433","citation":"91 FR 4794","html_url":"https://www.federalregister.gov/documents/2026/02/02/2026-02040/medicaid-program-preserving-medicaid-funding-for-vulnerable-populations-closing-a-health","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-02040"},{"document_number":"2026-01688","title":"Annual Civil Monetary Penalties Inflation Adjustment","publication_date":"2026-01-28","effective_date":null,"category":"other","sub_agency":"HHS","cfr_part":"45 CFR 102","citation":"91 FR 3665","html_url":"https://www.federalregister.gov/documents/2026/01/28/2026-01688/annual-civil-monetary-penalties-inflation-adjustment","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-01688"},{"document_number":"2026-00487","title":"Medicare Program; Updates to the Master List of Items Potentially Subject to Face to Face Encounter and Written Order Prior to Delivery and/or Prior Authorization Requirements; Updates to the Required Face-to-Face Encounter and Written Order Prior to Delivery List; and Updates to the Required Prior Authorization List","publication_date":"2026-01-13","effective_date":"2026-04-13","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 410","citation":"91 FR 1250","html_url":"https://www.federalregister.gov/documents/2026/01/13/2026-00487/medicare-program-updates-to-the-master-list-of-items-potentially-subject-to-face-to-face-encounter","canonical_url":"https://api.ai-analytics.org/hhs-rule/2026-00487"},{"document_number":"2025-24123","title":"Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications","publication_date":"2025-12-31","effective_date":"2026-01-01","category":"other","sub_agency":"HHS","cfr_part":"21 CFR 1307","citation":"90 FR 61301","html_url":"https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-24123"},{"document_number":"2025-23452","title":"COVID-19 Mitigation Policy Requirement in Head Start Programs; Recission","publication_date":"2025-12-19","effective_date":"2026-02-17","category":"mental-health","sub_agency":"SAMHSA","cfr_part":"45 CFR 1302","citation":"90 FR 59397","html_url":"https://www.federalregister.gov/documents/2025/12/19/2025-23452/covid-19-mitigation-policy-requirement-in-head-start-programs-recission","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-23452"},{"document_number":"2025-23413","title":"Medical Devices; Neurological Devices; Classification of the Electrical Tongue Nerve Stimulator To Treat Motor Deficits","publication_date":"2025-12-19","effective_date":"2025-12-19","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 882","citation":"90 FR 59377","html_url":"https://www.federalregister.gov/documents/2025/12/19/2025-23413/medical-devices-neurological-devices-classification-of-the-electrical-tongue-nerve-stimulator-to","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-23413"},{"document_number":"2025-23081","title":"Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2026 and Updates to the IRF Quality Reporting Program; Correction","publication_date":"2025-12-17","effective_date":"2025-12-17","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 412","citation":"90 FR 58509","html_url":"https://www.federalregister.gov/documents/2025/12/17/2025-23081/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-23081"},{"document_number":"2025-21955","title":"Medical Devices; Quality Management System Regulation Technical Amendments","publication_date":"2025-12-04","effective_date":"2026-02-02","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 801","citation":"90 FR 55978","html_url":"https://www.federalregister.gov/documents/2025/12/04/2025-21955/medical-devices-quality-management-system-regulation-technical-amendments","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-21955"},{"document_number":"2025-21962","title":"Expiration of Interim Final Rule: Control of Communicable Diseases; Foreign Quarantine","publication_date":"2025-12-04","effective_date":"2025-12-04","category":"public-health","sub_agency":"CDC","cfr_part":"42 CFR 71","citation":"90 FR 55813","html_url":"https://www.federalregister.gov/documents/2025/12/04/2025-21962/expiration-of-interim-final-rule-control-of-communicable-diseases-foreign-quarantine","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-21962"},{"document_number":"2025-21792","title":"Medicare and Medicaid Programs; Repeal of Minimum Staffing Standards for Long-Term Care Facilities","publication_date":"2025-12-03","effective_date":"2026-02-02","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 483","citation":"90 FR 55687","html_url":"https://www.federalregister.gov/documents/2025/12/03/2025-21792/medicare-and-medicaid-programs-repeal-of-minimum-staffing-standards-for-long-term-care-facilities","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-21792"},{"document_number":"2025-21767","title":"Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies","publication_date":"2025-12-02","effective_date":"2026-01-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 405","citation":"90 FR 55342","html_url":"https://www.federalregister.gov/documents/2025/12/02/2025-21767/medicare-and-medicaid-programs-calendar-year-2026-home-health-prospective-payment-system-hh-pps-rate","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-21767"},{"document_number":"2025-21458","title":"Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction","publication_date":"2025-11-28","effective_date":"2025-11-28","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 405","citation":"90 FR 54589","html_url":"https://www.federalregister.gov/documents/2025/11/28/2025-21458/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-21458"},{"document_number":"2025-21218","title":"Medical Devices; Neurological Devices; Classification of Field Generator Positioning Device","publication_date":"2025-11-26","effective_date":"2025-11-26","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 882","citation":"90 FR 54232","html_url":"https://www.federalregister.gov/documents/2025/11/26/2025-21218/medical-devices-neurological-devices-classification-of-field-generator-positioning-device","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-21218"},{"document_number":"2025-21217","title":"Medical Devices; Gastroenterology-Urology Devices; Classification of the Anchored Esophageal Sheath","publication_date":"2025-11-26","effective_date":"2025-11-26","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 876","citation":"90 FR 54230","html_url":"https://www.federalregister.gov/documents/2025/11/26/2025-21217/medical-devices-gastroenterology-urology-devices-classification-of-the-anchored-esophageal-sheath","canonical_url":"https://api.ai-analytics.org/hhs-rule/2025-21217"}]}